Multiple Myeloma Diagnostic Criteria – Online Calculator

For Multiple Myeloma Diagnostic Criteria assessment necessary to provide selection of the appropriate criteria:
Criteria
(A) Clonal bone marrow plasma cells ≥10% or (B) biopsy-proven bony or extramedullary plasmacytoma
AND
(C) ≥1 myeloma defining event (C1 or C2):
- (C1) End organ damage attributable underlying plasma cell proliferative disorder, specifically:
- Hypercalcemia: serum calcium >1 mg/dL (>0.25 mmol/L) higher than upper limit of normal or >11 mg/dL (>2.75 mmol/L)
- Renal insufficiency: creatinine clearance <40 mL per min or serum creatinine >2 mg/dL (177 μmol/L)
- Anemia: hemoglobin >2 g/dL (20 g/L) below lower limit of normal, or hemoglobin <10 g/dL (100 g/L)
- Bone lesions: ≥1 osteolytic lesion on skeletal x-ray, CT, or PET-CT
- (C2) ≥1 of the following biomarkers of malignancy:
- Clonal bone marrow plasma cells ≥60%
- Involved:uninvolved sFLC ratio ≥100
- >1 focal lesion on MRI
Register on our website right now to have access to more learning materials!
Subscribe to our pages:
Literature
Revised Multiple Myeloma International Staging System (R-ISS) Online Calculator
Revised Multiple Myeloma International Staging System (R-ISS) – prognostication tool for myeloma patients based on…
Multiple Myeloma International Staging System (ISS) Online Calculator
Multiple Myeloma International Staging System (ISS) prognosticates the severity of multiple myeloma based on routinely…
SAVED VTE Score
SAVED score for venous thromboembolism risk stratification in patients with multiple myeloma receiving immunomodulators. [ezfc…
IMPEDE VTE Score
IMPEDE score for venous thromboembolism risk stratification in patients with multiple myeloma receiving immunomodulators. [ezfc…
IPSET – Thrombosis Risk for essential thrombocythemia: Online Calculator
International Prognostic Score of thrombosis in World Health Organization – essential thrombocythemia (IPSET-thrombosis). IPSET-thrombosis model…